Med Biogene Inc (TSE:MBI.H)
TSXV:MBI.H
Canadian Market

Med Biogene (MBI.H) Financial Statements

3 Followers

Med Biogene Financial Overview

Med Biogene's market cap is currently ―. The company's EPS TTM is C$-0.004; its P/E ratio is -3.41; Med Biogene is scheduled to report earnings on August 23, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.13K$ -11.22K$ -15.01K$ -20.60K$ -11.29K
EBITDA$ -10.13K$ -11.22K$ -15.01K$ -20.60K$ -11.29K
Net Income Common Stockholders$ -10.13K$ -11.22K$ -15.01K$ -20.60K$ -11.29K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.02K$ 713.00$ 208.00$ 1.16K$ 726.00
Total Assets$ 14.22K$ 2.31K$ 6.46K$ 12.77K$ 14.06K
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -1.02K$ -713.00$ -208.00$ -1.16K$ -726.00
Total Liabilities$ 148.33K$ 129.30K$ 119.44K$ 112.88K$ 91.63K
Stockholders Equity$ -134.10K$ -126.98K$ -112.98K$ -100.11K$ -77.56K
Cash Flow-
Free Cash Flow$ -2.71K$ 3.29K$ -3.09K$ 2.38K$ 364.00
Operating Cash Flow$ -2.71K$ 3.29K$ -3.09K$ 2.38K$ 364.00
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Med Biogene Earnings and Revenue History

Med Biogene Debt to Assets

Med Biogene Cash Flow

Med Biogene Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis